ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC Meeting Move To Jan. 31 In Jacksonville; ACS Gynecologic Cancer Meeting Sept. 18-20 In Phila.

August 22, 1975

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983